Get startedLog in
    Picture of Newbury Pharmaceuticals AB logo

    NEWBRY — Newbury Pharmaceuticals AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: Newbury Pharmaceuticals Q1 EBITDA Loss Widens To SEK 3.76 Mln

    Picture of Newbury Pharmaceuticals AB logoNewbury Pharmaceuticals AB
    24/01/2025 07:01
    Jan 24 (Reuters) - Newbury Pharmaceuticals AB
 NEWBRY.ST :
    * Q1 EBITDA WAS -3 759 (-2 734) TKR.
    * Q1 REVENUE SEK 6.5 MILLION VERSUS SEK 11.2 MILLION YEAR
AGO
    * WE CONTINUE TO SEE STRONG SALES DEVELOPMENT IN NORDIC
MARKETS

Source text:  ID:nMFN6HWy9h 
Further company coverage:  NEWBRY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Newbury Pharmaceuticals AB

    See all news